SIBN (US) share price forecast & AI signal — SI-BONE, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in SIBN
SI-BONE, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About SI-BONE, Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $24.24 |
| 2026-11-05 | $24.27 |
| 2026-11-04 | $24.95 |
| 2026-11-03 | $23.77 |
| 2026-11-02 | $20.22 |
| 2026-10-30 | $21.23 |
| 2026-10-29 | $22.41 |
SIBN FAQ
Is SI-BONE, Inc (SIBN) a buy or sell this week?
The ACE Stock Bots machine-learning model rates SIBN a SELL for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for SIBN?
Every week the model scores SIBN across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.